Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+47.3%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+47.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.2x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 151.59% |
| 2024 | -5.29% |
| 2023 | -130.78% |
| 2022 | 47.39% |
| 2021 | -57.40% |
| 2020 | -32.37% |
| 2019 | -174.73% |
| 2018 | -116.46% |
| 2017 | 0.00% |